Celiac disease (CD) presents as chronic low-grade inflammation of the small intestine often characterized by psychiatric comorbidities. The brain-derived neurotrophic factor (BDNF), which we have shown to be reduced in the serum of CD patients, acts as the bridge between immune activation and the nervous system adaptive response. Since has been shown to upregulate BDNF, this study aimed to evaluate whether the administration of GG (L.GG) could positively affect the brain BDNF system in rats mimicking the CD lesions. Data have shown that the administration of pepsin-trypsin digested gliadin (PTG) and L.GG alter the levels of mature BDNF (mBDNF), as evaluated by Western blotting. PTG provoked a reduction of mBDNF compared to controls, and a compensatory increase of its receptor TrkB. L.GG induced a slight positive effect on mBDNF levels under normal conditions, while it was able to rescue the PTG-induced reduced expression of mBDNF. The curative effect of L.GG was finely tuned, accompanied by the reduction of TrkB, probably to avoid the effect of excessive BDNF.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146293PMC
http://dx.doi.org/10.3390/nu12030629DOI Listing

Publication Analysis

Top Keywords

bdnf system
8
bdnf
6
system brain
4
brain samples
4
samples wistar
4
wistar rats
4
rats pepsin-trypsin-digested
4
pepsin-trypsin-digested gliadin
4
gliadin ptg-induced
4
ptg-induced enteropathy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!